RevBio, Inc. is a clinical-stage medical device company focused on developing and commercializing a patented synthetic bone adhesive biomaterial called Tetranite. This injectable and self-setting material is being developed for dental, cranial, orthopedic, and animal health applications. RevBio has partnered with the ISS National Laboratory and SpaceX to conduct experiments on the International Space Station to study Tetranite's bone regeneration capabilities in microgravity. Key partners and investors include Pacific Dental Services, Greyhill Ventures, and Revere Partners.
All verified mentions of this organization in source documents.
No mentions found for this organization.